Patent Fee Hikes Backed By Device Firms, Assuming PTO Retains Funds
This article was originally published in The Gray Sheet
Executive Summary
Legislative proposals for fee structure changes within the U.S. Patent & Trademark Office could reduce costly litigation and IP uncertainty, bill supporters say
You may also be interested in...
Patent Application Fees 50% Higher Under PTO Proposal, MDMA Maintains
The U.S. Patent and Trademark Office's proposed patent application fee structure for FY 2003 will force smaller device firms to alter their applications to cut costs, MDMA asserts in a Sept. 4 letter to PTO Director James Rogan
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.